Phase I dose-escalation trial of ONT-380 in combination with trastuzumab in patients (pts) with HER2+breast cancer brain metastases

Authors
Category Primary study
JournalCANCER RESEARCH
Year 2017
This article has no abstract
Epistemonikos ID: 49db37190d6905636d17794742349a8fabceacc8
First added on: Feb 08, 2025